| Category: | Health, |
|---|---|
| Address: | 8788 River Rd, Delta, BC V4G 1B5, Canada |
| Postal code: | V4G 1B5 |
| Phone: | (866) 210-1420 |
| Website: | http://vodis.ca/ |
There are no reviews yet!
You can review this Business and help others by leaving a comment. If you want to share your thoughts about Vodis Innovative Pharmaceuticals, use the form below and your opinion, advice or comment will appear in this space.
Founded in 2011, Vodis Pharmaceuticals started as Southbridge Resources Corp, a mineral property exploration company in British Columbia. In 2014, as it fully shifted to the pharma industry, it became Vodis Pharmaceuticals, Inc and acquired Vodis Innovative Pharmaceuticals, Inc.
Sean Cote Board of Directors As Chief Executive Officer at Vodis Pharmaceuticals Inc. ... (866) 210-1420. Access Sean's Contact Information. Free Prospecting Tool.
Southbridge To Review Vodis Innovative Pharmaceuticals Inc. Southbridge Resources Corp. ("Southbridge") is pleased to announce that it has entered into a letter agreement to conduct a due diligence review of the proposed business of Vodis Innovative Pharmaceuticals Inc. ("VODIS").
For more information, please visit the company's website www.vodis.ca or contact Otto Folprecht for investor inquires at 1-866-210-1420 or email otto@vodis.ca. I'm Samantha Deutscher for Investmentpitch media For more video news, and to view our disclaimer, please visit our website at www.investmentpitch.com
Southbridge Agrees To Acquire Vodis Innovative Pharmaceuticals Inc Further to the news release of June 30, 2014, Southbridge Resources Corp. ("Southbridge") is pleased to announce that it has received shareholder consent to the acquisition of Vodis Innovative Pharmaceuticals Inc. and expects the transaction to close within a week.
Vodis Innovative Pharmaceuticals Inc. 8788 River Rd, Delta, V4G 1B4, Canada. Phone: 1.866.210.1420 Ext.103. Website: www.vodis.ca. The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof. Forward-Looking Information:
Phone: 1.866.210.1420 Ext.103 Website: www.vodis.ca The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release and accepts no responsibility for the ...
Interested accredited investors and other investors or shareholders who qualify under applicable securities laws to participate in the financing, can contact the Company at 1-866-210-1420 Ext. 102.
2. Oktober 2014 - Vancouver, British Columbia - Vodis Pharmaceuticals Inc. (das Unternehmen oder Vodis) (CSE: VP / FWB: 1JV)) freut sich bekannt zu geben, dass das Unternehmen eine 100%ige ...